SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Angiotech Pharmaceuticals Inc, et al. – ‘F-10’ on 3/8/07 – EX-25.1

On:  Thursday, 3/8/07, at 5:20pm ET   ·   Accession #:  1193125-7-49659   ·   File #s:  333-141155, -01, -02, -03, -04, -05, -06, -07, -08, -09, -10, -11, -12, -13, -14, -15, -16, -17, -18, -19, -20, -21, -22, -23, -24, -25, -26, -27, -28, -29, -30, -31, -32, -33, -34

Previous ‘F-10’:  ‘F-10/A’ on 12/13/06   ·   Next & Latest:  ‘F-10/A’ on 4/2/07

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/08/07  Angiotech Pharmaceuticals Inc     F-10                  16:2.6M                                   RR Donnelley/FA
          0761717 B.C. Ltd.
          3091798 Nova Scotia Co
          Afmedica, Inc.
          0741693 B.C. Ltd.
          3091796 Nova Scotia Co
          3091799 Nova Scotia Co
          3129537 Nova Scotia Co
          3129538 Nova Scotia Co
          3129539 Nova Scotia Co
          3129540 Nova Scotia Co
          3129541 Nova Scotia Co
          3132933 Nova Scotia Co
          3132934 Nova Scotia Co
          3132935 Nova Scotia Co
          Tercentenary Holdings, Corp.
          3091797 Nova Scotia Co
          3132936 Nova Scotia Co
          American Medical Instruments Holdings, Inc.
          American Medical Instruments, Inc.
          Angiotech BioCoatings Corp.
          Angiotech Capital, LLC
          Angiotech International Holdings, Corp.
          Angiotech Investment Partnership
          Angiotech Pharmaceuticals (US), Inc.
          B.G. Sulzle, Inc.
          Crimson Cardinal Capital, Inc.
          Manan Medical Products, Inc.
          Medical Device Technologies, Inc.
          NeuColl, Inc.
          Point Technologies, Inc.
          Quill Medical, Inc.
          Surgical Specialties Corp.
          Surgical Specialties Puerto Rico, Inc.
          Surgical Specialties UK Holdings Ltd

Registration Statement of a Foreign Private Issuer (Not Effective Immediately)   —   Form F-10
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-10        Registration Statement of a Foreign Private Issuer  HTML   1.27M 
                          (Not Effective Immediately)                            
 2: EX-4.3      Indenture                                           HTML    665K 
 3: EX-5.1      Opinion of Sullivan & Cromwell LLP                  HTML     22K 
 4: EX-5.2      Opinion of Borden Ladner Gervais LLP                HTML     30K 
 5: EX-5.3      Opinion of Stewart McKelvey                         HTML     31K 
 6: EX-5.4      Opinion of Lionel Sawyer & Collins                  HTML     22K 
 7: EX-5.5      Opinion of Heller Ehrman White & McAuliffe LLP      HTML     44K 
 8: EX-5.6      Opinion of Faegre & Benson LLP                      HTML     30K 
 9: EX-5.7      Opinion of McConnell Valdes                         HTML     29K 
10: EX-5.8      Opinion of Herbert Smith LLP                        HTML     66K 
11: EX-23.1     Consent of Pricewaterhousecoopers LLP               HTML     16K 
12: EX-23.2     Consent of Ernst & Young LLP                        HTML     18K 
13: EX-23.3     Consent of Hughes Pittman & Gupton LLP              HTML     16K 
14: EX-25.1     Statement of Eligibility of the Trustee on Form     HTML     56K 
                          T-1                                                    
15: EX-99.1     Letter of Transmittal                               HTML     65K 
16: EX-99.2     Notice of Guaranteed Delivery                       HTML     27K 


EX-25.1   —   Statement of Eligibility of the Trustee on Form T-1


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  Statement of Eligibility of the Trustee on Form T-1  

EXHIBIT 25.1

 


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


FORM T-1

STATEMENT OF ELIGIBILITY

UNDER THE TRUST INDENTURE ACT OF 1939 OF A

CORPORATION DESIGNATED TO ACT AS TRUSTEE

 


CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE

PURSUANT TO SECTION 305(b)(2)

WELLS FARGO BANK, NATIONAL ASSOCIATION

(Exact name of trustee as specified in its charter)

 

Not Applicable   94-1347393
(Jurisdiction of incorporation or   (I.R.S. Employer
organization if not a U.S. national bank)   Identification No.)

 

420 Montgomery Street  
San Francisco, CA   94163
(Address of principal executive offices)   (Zip code)

Wells Fargo & Company

Law Department, Trust Section

MAC N9305-172

Sixth and Marquette, 17th Floor

Minneapolis, MN 55479

(agent for services)

 


Angiotech Pharmaceuticals, Inc.

(Exact name of obligor as specified in its charter)

 

Province of British Columbia   98-0226269
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
1618 Station Street  
Vancouver, B.C.   V6A 1B6
(Address of principal executive offices)   (Zip code)

 


SENIOR FLOATING RATE NOTES DUE 2013

(Title of the indenture securities)

 


 


Item 1. General Information. Furnish the following information as to the trustee:

 

  (a) Name and address of each examining or supervising authority to which it is subject.

Comptroller of the Currency,

Treasury Department

Washington, D.C. 20230

Federal Deposit Insurance Corporation

Washington, D.C. 20429

Federal Reserve Bank of San Francisco

San Francisco, CA 94120

 

  (b) Whether it is authorized to exercise corporate trust powers.

The trustee is authorized to exercise corporate trust powers.

Item 2. Affiliations with Obligor. If the obligor is an affiliate of the trustee, describe each such affiliation.

None with respect to the trustee.

No responses are included for Items 3-14 of this Form T-1 because the obligor is not in default as provided under Item 13.

 

Item 15.

   Foreign Trustee.    Not applicable.

Item 16.

   List of Exhibits.    List below all exhibits filed as a part of this Statement of Eligibility. Wells Fargo Bank incorporates by reference into this Form T-1 exhibits attached hereto.

 

Exhibit 1.    A copy of the Articles of Association of the trustee now in effect. *
Exhibit 2.    A copy of the Comptroller of the Currency Certificate of Corporate Existence for Wells Fargo Bank, National Association, dated November 28, 2001. *
Exhibit 3.    A copy of the authorization of the trustee to exercise corporate trust powers. A copy of the Comptroller of the Currency Certificate of Corporate Existence (with Fiduciary Powers) for Wells Fargo Bank, National Association, dated November 28, 2001. *
Exhibit 4.    Copy of By-laws of the trustee as now in effect. *
Exhibit 5.    Not applicable.
Exhibit 6.    The consents of United States institutional trustees required by Section 321(b) of the Act.
Exhibit 7.    Attached is a copy of the latest report of condition of the trustee published pursuant to law or the requirements of its supervising or examining authority.


Exhibit 8.    Not applicable.
Exhibit 9.    Not applicable.

 

* Incorporated by reference to exhibit number 25 filed with registration statement number 333-87398.

 


SIGNATURE

Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the trustee, Wells Fargo Bank, National Association, a national banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Los Angeles and State of California on this 12th day of January, 2007.

 

WELLS FARGO BANK, NATIONAL ASSOCIATION
/S/    MADDY HALL
Name:  Maddy Hall
Title:    Assistant Vice President


Exhibit 6

January 12, 2007

 

Securities and Exchange Commission

Washington, D.C. 20549

Gentlemen:

In accordance with Section 321(b) of the Trust Indenture Act of 1939, as amended, the undersigned hereby consents that reports of examination of the undersigned made by Federal, State, Territorial, or District authorities authorized to make such examination may be furnished by such authorities to the Securities and Exchange Commission upon its request thereof.

 

Very truly yours,
WELLS FARGO BANK, NATIONAL ASSOCIATION
/S/    MADDY HALL
Maddy Hall
Assistant Vice President


Consolidated Report of Condition of

Wells Fargo Bank National Association

of 101 North Phillips Avenue, Sioux Falls, SD 57104

And Foreign and Domestic Subsidiaries,

at the close of business September 30, 2006, filed in accordance with 12 U.S.C. §161 for National Banks.

 

          Dollar Amounts
In Millions

ASSETS

     

Cash and balances due from depository institutions:

     

Noninterest-bearing balances and currency and coin

      $ 12,568

Interest-bearing balances

        2,329

Securities:

     

Held-to-maturity securities

        0

Available-for-sale securities

        47,734

Federal funds sold and securities purchased under agreements to resell:

     

Federal funds sold in domestic offices

        4,359

Securities purchased under agreements to resell

        1,055

Loans and lease financing receivables:

     

Loans and leases held for sale

        39,455

Loans and leases, net of unearned income

   240,414   

LESS: Allowance for loan and lease losses

   2,226   

Loans and leases, net of unearned income and allowance

        238,188

Trading Assets

        3,850

Premises and fixed assets (including capitalized leases)

        4,012

Other real estate owned

        482

Investments in unconsolidated subsidiaries and associated companies

        374

Intangible assets

     

Goodwill

        8,912

Other intangible assets

        18,523

Other assets

        18,966
         

Total assets

      $ 400,807
         

LIABILITIES

     

Deposits:

     

In domestic offices

      $ 284,509

Noninterest-bearing

   77,344   

Interest-bearing

   207,165   

In foreign offices, Edge and Agreement subsidiaries, and IBFs

        32,180

Noninterest-bearing

   8   

Interest-bearing

   32,172   

Federal funds purchased and securities sold under agreements to repurchase:

     

Federal funds purchased in domestic offices

        3,274

Securities sold under agreements to repurchase

        6,805

 


     Dollar Amounts
In Millions

Trading liabilities

     2,957

Other borrowed money

  

(includes mortgage indebtedness and obligations under capitalized leases)

     4,705

Subordinated notes and debentures

     10,580

Other liabilities

     16,959
      

Total liabilities

   $ 361,969

Minority interest in consolidated subsidiaries

     58

EQUITY CAPITAL

  

Perpetual preferred stock and related surplus

     0

Common stock

     520

Surplus (exclude all surplus related to preferred stock)

     24,751

Retained earnings

     13,150

Accumulated other comprehensive income

     359

Other equity capital components

     0
      

Total equity capital

     38,780
      

Total liabilities, minority interest, and equity capital

   $ 400,807
      

I, Karen B. Nelson, Vice President of the above-named bank do hereby declare that this Report of Condition has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true to the best of my knowledge and belief.

Karen B. Nelson

Vice President

We, the undersigned directors, attest to the correctness of this Report of Condition and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.

Dave Hoyt

John Stumpf                                Directors

Carrie Tolstedt


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-10’ Filing    Date    Other Filings
Filed on:3/8/07F-X
1/12/07
9/30/066-K
11/28/01
 List all Filings 
Top
Filing Submission 0001193125-07-049659   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 9, 10:19:53.1pm ET